Compare Stocks: TMDX, SNN, GKOS, and GMED

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GKOS Glaukos	$178.97 +0.8%	$167.44	$73.16 ▼ $191.62	$10.56B	0.76	849,765 shs	25,764 shs
GMED Globus Medical	$77.86 -0.6%	$80.76	$54.15 ▼ $101.40	$10.42B	0.95	1.45 million shs	45,319 shs
SNN Smith & Nephew SNATS	$28.87 0.0%	$30.08	$28.48 ▼ $38.79	$12.14B	0.55	1.24 million shs	284,745 shs
TMDX TransMedics Group	$87.40 -2.9%	$80.60	$60.10 ▼ $156.00	$3.04B	1.9	1.03 million shs	25,731 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GKOS Glaukos	0.00%	-0.70%	-1.13%	+40.63%	+90.12%
GMED Globus Medical	0.00%	-3.89%	-4.79%	-5.24%	+29.27%
SNN Smith & Nephew SNATS	0.00%	+0.38%	-3.96%	-7.76%	-24.10%
TMDX TransMedics Group	0.00%	+6.02%	+7.26%	+21.12%	-13.49%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GKOS Glaukos	$178.97 +0.8%	$167.44	$73.16 ▼ $191.62	$10.56B	0.76	849,765 shs	25,764 shs
GMED Globus Medical	$77.86 -0.6%	$80.76	$54.15 ▼ $101.40	$10.42B	0.95	1.45 million shs	45,319 shs
SNN Smith & Nephew SNATS	$28.87 0.0%	$30.08	$28.48 ▼ $38.79	$12.14B	0.55	1.24 million shs	284,745 shs
TMDX TransMedics Group	$87.40 -2.9%	$80.60	$60.10 ▼ $156.00	$3.04B	1.9	1.03 million shs	25,731 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GKOS Glaukos	0.00%	-0.70%	-1.13%	+40.63%	+90.12%
GMED Globus Medical	0.00%	-3.89%	-4.79%	-5.24%	+29.27%
SNN Smith & Nephew SNATS	0.00%	+0.38%	-3.96%	-7.76%	-24.10%
TMDX TransMedics Group	0.00%	+6.02%	+7.26%	+21.12%	-13.49%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GKOS Glaukos	2.79	Moderate Buy	$178.08	-0.07% Downside
GMED Globus Medical	2.88	Moderate Buy	$101.77	30.02% Upside
SNN Smith & Nephew SNATS	1.91	Reduce	$30.93	6.97% Upside
TMDX TransMedics Group	2.38	Hold	$124.18	38.01% Upside

Current Analyst Ratings Breakdown

Latest TMDX, SNN, GKOS, and GMED Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/4/2026	SNN Smith & Nephew SNATS	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
9/2/2026	SNN Smith & Nephew SNATS	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight
8/31/2026	TMDX TransMedics Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/31/2026	SNN Smith & Nephew SNATS	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral
8/20/2026	GKOS Glaukos	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$193.00 ➝ $202.00
8/10/2026	GMED Globus Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/7/2026	GMED Globus Medical	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$103.00 ➝ $99.00
8/7/2026	SNN Smith & Nephew SNATS	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/6/2026	SNN Smith & Nephew SNATS	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight ➝ Neutral
8/5/2026	SNN Smith & Nephew SNATS	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
8/5/2026	SNN Smith & Nephew SNATS	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Equal Weight ➝ Underweight

(Data available from 9/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GKOS Glaukos	$507.44M	20.71	N/A	N/A	$11.42 per share	15.60
GMED Globus Medical	$2.94B	3.58	$6.28 per share	12.46	$33.86 per share	2.31
SNN Smith & Nephew SNATS	$6.16B	1.97	$3.43 per share	8.42	$12.45 per share	2.32
TMDX TransMedics Group	$605.49M	5.14	$3.93 per share	22.91	$13.79 per share	6.53

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GKOS Glaukos	-$187.69M	-$3.25	N/A	349.41	N/A	-30.68%	-6.37%	-4.78%	11/4/2026 (Estimated)
GMED Globus Medical	$537.87M	$3.91	20.02	14.52	1.26	17.02%	14.57%	12.62%	11/5/2026 (Estimated)
SNN Smith & Nephew SNATS	$625M	N/A	N/A	12.15	1.07	N/A	N/A	N/A	N/A
TMDX TransMedics Group	$190.29M	$3.89	23.13	39.81	N/A	22.69%	15.88%	5.95%	11/4/2026 (Estimated)

Latest TMDX, SNN, GKOS, and GMED Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	GMED Globus Medical	$1.10	$1.34	+$0.24	$1.10	$782.88 million	$789.61 million
8/4/2026	Q2 2026	TMDX TransMedics Group	$0.4955	$0.44	-$0.0555	$0.41	$184.00 million	$189.95 million
7/29/2026	Q2 2026	GKOS Glaukos	-$0.2105	-$0.14	+$0.0705	-$0.31	$150.93 million	$185.61 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
GMED Globus Medical	N/A	N/A	N/A	N/A	N/A
SNN Smith & Nephew SNATS	$0.93	3.22%	N/A	N/A	N/A
TMDX TransMedics Group	N/A	N/A	N/A	N/A	N/A

Latest TMDX, SNN, GKOS, and GMED Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2026	SNN Smith & Nephew SNATS		$0.3120	2.05%	10/2/2026	10/2/2026	11/6/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GKOS Glaukos	0.10	5.04	4.46
GMED Globus Medical	N/A	4.62	2.93
SNN Smith & Nephew SNATS	0.62	2.14	1.11
TMDX TransMedics Group	1.62	6.62	6.07

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GKOS Glaukos	99.04%
GMED Globus Medical	95.16%
SNN Smith & Nephew SNATS	25.64%
TMDX TransMedics Group	99.67%

Insider Ownership

Company	Insider Ownership
GKOS Glaukos	5.90%
GMED Globus Medical	18.38%
SNN Smith & Nephew SNATS	1.00%
TMDX TransMedics Group	6.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GKOS Glaukos	1,094	58.98 million	55.50 million	Optionable
GMED Globus Medical	6,000	134.26 million	109.59 million	Optionable
SNN Smith & Nephew SNATS	16,988	419.93 million	415.73 million	Optionable
TMDX TransMedics Group	210	34.56 million	32.18 million	Optionable

TMDX, SNN, GKOS, and GMED Headlines

Recent News About These Companies

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

September 7 at 3:03 PM | prnewswire.com

Jupiter Topco LLC Makes New Investment in TransMedics Group, Inc. $TMDX

September 6 at 4:40 AM | marketbeat.com

TransMedics Group, Inc. $TMDX Position Increased by Wellington Management Group LLP

September 5 at 4:47 AM | marketbeat.com

The Manufacturers Life Insurance Company Acquires Shares of 17,159 TransMedics Group, Inc. $TMDX

September 5 at 4:47 AM | marketbeat.com

TransMedics Group, Inc. $TMDX Position Increased by FirstWave Capital Management LLC

September 5 at 4:23 AM | marketbeat.com

19,289 Shares in TransMedics Group, Inc. $TMDX Bought by Corient Private Wealth LP

September 5 at 3:44 AM | marketbeat.com

Legal & General Group Plc Invests $5.29 Million in TransMedics Group, Inc. $TMDX

September 4, 2026 | marketbeat.com

TransMedics Group, Inc. $TMDX Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

September 4, 2026 | marketbeat.com

Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?

September 3, 2026 | zacks.com

Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?

September 3, 2026 | zacks.com

Braidwell LP Has $40.50 Million Position in TransMedics Group, Inc. $TMDX

September 3, 2026 | marketbeat.com

TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX

September 2, 2026 | globenewswire.com

Empowered Funds LLC Purchases New Stake in TransMedics Group, Inc. $TMDX

September 2, 2026 | marketbeat.com

193,752 Shares in TransMedics Group, Inc. $TMDX Purchased by Bank of New York Mellon Corp

September 2, 2026 | marketbeat.com

Headlands Technologies LLC Purchases Shares of 24,599 TransMedics Group, Inc. $TMDX

September 1, 2026 | marketbeat.com

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX

August 31, 2026 | prnewswire.com

TransMedics to Present at Upcoming September Investor Conferences

August 31, 2026 | prnewswire.com

TransMedics Group (NASDAQ:TMDX) Trading Down 5.5% - Time to Sell?

August 31, 2026 | marketbeat.com

TransMedics Group, Inc. $TMDX Shares Sold by Beaconlight Capital LLC

August 31, 2026 | marketbeat.com

TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX

August 29, 2026 | globenewswire.com

Algert Global LLC Purchases 31,710 Shares of TransMedics Group, Inc. $TMDX

August 29, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDX, SNN, GKOS, and GMED Company Descriptions

Glaukos NYSE:GKOS

$178.97 +1.50 (+0.85%)

As of 10:08 AM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Globus Medical NYSE:GMED

$77.86 -0.43 (-0.55%)

As of 10:08 AM Eastern

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Smith & Nephew SNATS NYSE:SNN

$28.86 -0.01 (-0.02%)

As of 10:08 AM Eastern

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

TransMedics Group NASDAQ:TMDX

$87.40 -2.58 (-2.87%)

As of 10:08 AM Eastern

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TMDX, SNN, GKOS, and GMED Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TMDX, SNN, GKOS, and GMED Earnings

Compare Dividends

Latest TMDX, SNN, GKOS, and GMED Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TMDX, SNN, GKOS, and GMED Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDX, SNN, GKOS, and GMED Company Descriptions

Glaukos NYSE:GKOS

Globus Medical NYSE:GMED

Smith & Nephew SNATS NYSE:SNN

TransMedics Group NASDAQ:TMDX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TMDX, SNN, GKOS, and GMED Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TMDX, SNN, GKOS, and GMED Earnings

Compare Dividends

Latest TMDX, SNN, GKOS, and GMED Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TMDX, SNN, GKOS, and GMED Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDX, SNN, GKOS, and GMED Company Descriptions

Glaukos NYSE:GKOS

Globus Medical NYSE:GMED

Smith & Nephew SNATS NYSE:SNN

TransMedics Group NASDAQ:TMDX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools